Home > Resources > Whitepapers > New Active Substances Launched During 2021

RESEARCH

New Active Substances Launched During 2021

June 27, 2022

New Active
Following on from our review of trends in the current pharmaceutical R&D pipeline this supplement takes a look at the industry’s success stories of 2021

I'm For Real

Enter your details once to access all our information and resources

 

Spotlight

ISIS Pharma Consulting

We are Isis Pharma Consulting Ltd and we specialise in the provision of Quality Assurance, Qualified Person and Regulatory Affairs services to pharmaceutical, medical device and healthcare sectors. The company provides highly experienced Qualified Persons dedicated to providing a range of QP solutions for your business. We have QP, RP and Quality Management experience with IMPs, and commercial pharmaceutical manufacturing and also wholesaling and distribution organisations. We are also able to provide highly experienced regulatory personnel with up to date knowledge of current regulatory procedures and agency expectations.

OTHER WHITEPAPERS
news image

Helping Patients Find and Engage with Clinical Trials

whitePaper | June 16, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible

Read More
news image

High Pressure Homogenizer for Nano-formulation

whitePaper | December 16, 2022

NanoGenizer, a lab-scale microfluidic high pressure homogenizer, utilizes interaction high-pressure microfluidic jet technology, and it is equipped with highly modular power and processing units.

Read More
news image

Application Notes & Whitepapers 2019

whitePaper | December 19, 2019

Welcome to European Pharmaceutical Review’s Application Notes & Whitepapers Supplement 2019. This year’s topics range from analytical techniques for bioprocess investigation, host cell protein analysis and Raman imaging to advice on outsourcing services for product characterisation.

Read More
news image

Elemental Impurity Analysis in Pharmaceuticals

whitePaper | December 16, 2022

commenced work on a new standard to provide a global policy to limit these impurities in drug products and ingredients.

Read More
news image

Pharma R&D Annual Review 2022

whitePaper | May 5, 2022

welcome to pharmaprojects'2022 review of trends in pharmaceutical R&D for 30 year now, I've been taking an anual look at the evloution of pharma

Read More
news image

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO) to support the conversion.

Read More

Helping Patients Find and Engage with Clinical Trials

whitePaper | June 16, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible

Read More

High Pressure Homogenizer for Nano-formulation

whitePaper | December 16, 2022

NanoGenizer, a lab-scale microfluidic high pressure homogenizer, utilizes interaction high-pressure microfluidic jet technology, and it is equipped with highly modular power and processing units.

Read More

Application Notes & Whitepapers 2019

whitePaper | December 19, 2019

Welcome to European Pharmaceutical Review’s Application Notes & Whitepapers Supplement 2019. This year’s topics range from analytical techniques for bioprocess investigation, host cell protein analysis and Raman imaging to advice on outsourcing services for product characterisation.

Read More

Elemental Impurity Analysis in Pharmaceuticals

whitePaper | December 16, 2022

commenced work on a new standard to provide a global policy to limit these impurities in drug products and ingredients.

Read More

Pharma R&D Annual Review 2022

whitePaper | May 5, 2022

welcome to pharmaprojects'2022 review of trends in pharmaceutical R&D for 30 year now, I've been taking an anual look at the evloution of pharma

Read More

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO) to support the conversion.

Read More
More Whitepapers

Spotlight

ISIS Pharma Consulting

We are Isis Pharma Consulting Ltd and we specialise in the provision of Quality Assurance, Qualified Person and Regulatory Affairs services to pharmaceutical, medical device and healthcare sectors. The company provides highly experienced Qualified Persons dedicated to providing a range of QP solutions for your business. We have QP, RP and Quality Management experience with IMPs, and commercial pharmaceutical manufacturing and also wholesaling and distribution organisations. We are also able to provide highly experienced regulatory personnel with up to date knowledge of current regulatory procedures and agency expectations.

Events

6th Annual Conference Pharmaceutical Microbiology East Coast

Conference